TP53 and neoplasm: However, it was recently reported that ATO can reactivate p53 mutants that carry structural variations within the DNA binding domain via direct binding and allosteric activation, leading to the rescue of p53 transcriptional activity and tumor-suppressive functions (Chen et al, 2021).